BASIC RESEARCH
Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts
Tzu-Hurng Cheng, PhD* ,
Pao-Yun Cheng, MS ,
Neng-Lang Shih, PhD ,
Iuan-Bor Chen, BS ||,
Danny Ling Wang, PhD and
Jin-Jer Chen, MD ,*
* Department of Medicine, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.
|| Present address: Faculty of Art and Science, University of Toronto, Toronto, Ontario, Canada
Manuscript received May 27, 2003;
accepted June 4, 2003.
* Reprint requests and correspondence: Dr. Jin-Jer Chen, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, R.O.C. thcheng{at}gate.sinica.edu.tw
Presented at the International Young Investigator Prize Symposium at the XIVthWorld Congress of Cardiology.
OBJECTIVES: The aim of this study was to investigate the effects of angiotensin II (Ang II) on fibroblast proliferation and endothelin-1 (ET-1) gene induction, focusing especially on reactive oxygen species (ROS)-mediated signaling in cardiac fibroblasts.
BACKGROUND: Angiotensin II increases ET-1 expression, which plays an important role in Ang II-induced fibroblast proliferation. Angiotensin II also stimulates ROS generation in cardiac fibroblasts. However, whether ROS are involved in Ang II-induced proliferation and ET-1 expression remains unknown.
METHODS: Cultured neonatal rat cardiac fibroblasts were stimulated with Ang II, and then [3H]thymidine incorporation and the ET-1 gene expression were examined. We also examined the effects of antioxidants on Ang II-induced proliferation and mitogen-activated protein kinase (MAPK) phosphorylation to elucidate the redox-sensitive pathway in fibroblast proliferation and ET-1 gene expression.
RESULTS: Both AT1 receptor antagonist (losartan) and ETA receptor antagonist (BQ485) inhibited Ang II-increased DNA synthesis. Endothelin-1 gene was induced with Ang II as revealed by Northern blotting and promoter activity assay. Angiotensin II increased intracellular ROS levels, which were inhibited with losartan and antioxidants. Antioxidants further suppressed Ang II-induced ET-1 gene expression, DNA synthesis, and MAPK phosphorylation. PD98059, but not SB203580, fully inhibited Ang II-induced ET-1 expression. Truncation and mutational analysis of the ET-1 gene promoter showed that AP-1 binding site was an important cis-element in Ang II-induced ET-1 gene expression.
CONCLUSIONS: Our data suggest that ROS are involved in Ang II-induced proliferation and ET-1 gene expression. Our findings imply that the combination of ATI and ETA receptor antagonists plus antioxidants may be beneficial in preventing the formation of excessive cardiac fibrosis.
|
Abbreviations and Acronyms
| | Ang II | = angiotensin II | | AP-1 | = activator protein-1 | | AT1 | = angiotensin II type 1 receptor | | CAT | = chloramphenicol acetyltransferase | | DCF-DA | = dichlorofluorescin diacetate | | DPI | = diphenyleneiodonium | | ECM | = extracellular matrix | | ERK | = extracellular signal-regulated kinase | | ETA | = ET-1 type A receptor | | ET-1 | = endothelin-1 | | GPCRs | = G-protein coupled receptors | | JNK | = c-Jun N-terminal kinase | | MAPK | = mitogen-activated protein kinase | | MEK | = MAPK/ERK kinase | | mRNA | = messenger RNA | | NAC | = N-acetylcysteine | | redox | = cellular oxidation reduction | | ROS | = reactive oxygen species |
|
This article has been cited by other articles:

|
 |

|
 |
 
C. M. Troncoso Brindeiro, A. Q. da Silva, K. J. Allahdadi, V. Youngblood, and N. L. Kanagy
Reactive oxygen species contribute to sleep apnea-induced hypertension in rats
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H2971 - H2976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Leask
TGF{beta}, cardiac fibroblasts, and the fibrotic response
Cardiovasc Res,
May 1, 2007;
74(2):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Takimoto and D. A. Kass
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Hypertension,
February 1, 2007;
49(2):
241 - 248.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Cardiovasc Res,
July 15, 2006;
71(2):
208 - 215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Suganuma, Y. Zuo, N. Ayabe, J. Ma, V. R. Babaev, M. F. Linton, S. Fazio, I. Ichikawa, A. B. Fogo, and V. Kon
Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction
J. Am. Soc. Nephrol.,
February 1, 2006;
17(2):
433 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. An, R. Boyd, Y. Wang, X. Qiu, and H. D. Wang
Endothelin-1 expression in vascular adventitial fibroblasts
Am J Physiol Heart Circ Physiol,
February 1, 2006;
290(2):
H700 - H708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H-H Chao, J-J Chen, C-H Chen, H Lin, C-F Cheng, W-S Lian, Y-L Chen, S-H Juan, J-C Liu, J-Y Liou, et al.
Inhibition of angiotensin II induced endothelin-1 gene expression by 17-{beta}-oestradiol in rat cardiac fibroblasts
Heart,
May 1, 2005;
91(5):
664 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tsujimoto, S. Hikoso, O. Yamaguchi, K. Kashiwase, A. Nakai, T. Takeda, T. Watanabe, M. Taniike, Y. Matsumura, K. Nishida, et al.
The Antioxidant Edaravone Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy
Hypertension,
May 1, 2005;
45(5):
921 - 926.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|